Our partner Kenny van Kampen, PhD, from ReGEN Biomedical recently participated on the Tecan-hosted webinar, “Small Tissues, Big Impact: Biology and Technology of Microtissue Production.” The session provided a deep dive into the biological foundations of #microtissues and the engineering required to produce them at scale. Dr. van Kampen offered a comprehensive look at how these tiny biological building blocks are reshaping research, focusing specifically on the automated production processes that ensure the reliability and consistency needed for modern regenerative medicine.
An highlight of the presentation was the demonstration of the automated workflow used at ReGEN, with the m2M project serving as a standout example. By showcasing how automation facilitates large-scale microtissue generation, the session illustrated a critical bridge to advanced bioprinting. The ability to produce uniform tissues consistently is a game-changer for downstream applications, moving the field closer to high-throughput, reproducible tissue engineering.